Clinical trial
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse…
NCT00018954 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00018954 |
|---|---|
| Title | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma |
| Official title | PILOT MULTINATIONAL PROTOCOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA AND DIFFUSE NON-HODGKIN'S LYMPHOMA |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, doxorubicin hydrochloride, etoposide, ifosfamide, mercaptopurine, methotrexate, prednisone and 3 more |
| Start date | Oct 1, 1992 |
| Completion | Oct 1, 2002 |
| First posted | Jun 12, 2003 |
| Last update posted | Feb 20, 2012 |
| Countries | Egypt, India, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: